Borrowing Information Across Subgroups in Phase II Trials: Is It Useful?

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-1223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Pharmacogenomics in Early-Phase Oncology Clinical Trials: Is There a Sweet Spot in Phase II?

Clinical Cancer Research
Cancer ResearchOncology
2012English

Is It Time to Conduct Phase 3 Clinical Trials of Sex Hormones in MS – Commentary

Multiple Sclerosis
Neurology
2018English

Procalcitonin and Pneumonia: Is It a Useful Marker?

Current Infectious Disease Reports
Infectious Diseases
2007English

Between-Arm Comparisons in Randomized Phase II Trials

Journal of Biopharmaceutical Statistics
StatisticsProbabilityPharmacology
2009English

Phase II Cancer Trials: Out of Control?

Clinical Cancer Research
Cancer ResearchOncology
2007English

Rifabutin: Is It Useful in the Treatment of Multidrug-Resistant Tuberculosis?

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Phase II Trials Powered to Detect Tumor Subtypes

Clinical Cancer Research
Cancer ResearchOncology
2011English

Epinephrine Auto-Injector Use on YouTube: Is It Really Useful?

Eurasian Journal of Emergency Medicine
2019English

All-Comers Versus Enrichment Design Strategy in Phase II Trials

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy